USPHARMA
USPHARMA, officially known as US Pharma Limited, is a prominent player in the pharmaceutical industry, headquartered in the United States. Founded in 2001, the company has established a strong presence in key operational regions, including North America and Europe, focusing on the development and distribution of high-quality generic and specialty pharmaceuticals. With a commitment to innovation, USPHARMA offers a diverse portfolio of products, including prescription medications and over-the-counter solutions, distinguished by their efficacy and affordability. The company has achieved significant milestones, including regulatory approvals and partnerships that enhance its market position. Recognised for its dedication to quality and patient care, USPHARMA continues to make strides in the competitive pharmaceutical landscape, solidifying its reputation as a trusted provider of healthcare solutions.
DitchCarbon Score
How does USPHARMA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
USPHARMA's score of 3 is lower than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.
USPHARMA's reported carbon emissions
USPHARMA, headquartered in the United States, currently does not have publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their carbon footprint or the scope of their emissions (Scope 1, 2, or 3). However, the company is likely to be engaged in industry-standard climate commitments, which may include initiatives aimed at reducing greenhouse gas emissions and enhancing sustainability practices. As the pharmaceutical industry increasingly focuses on climate action, USPHARMA may be aligning its strategies with broader environmental goals, although specific details on their commitments or initiatives are not provided.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
USPHARMA is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
